There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Legend Biotech (LEGN – Research Report), Green Thumb Industries (GTBIF – Research Report) and OmniAb (OABI – Research Report) with bullish sentiments.
Legend Biotech (LEGN)
Jefferies analyst Kelly Shi maintained a Buy rating on Legend Biotech today and set a price target of $94.00. The company’s shares closed last Monday at $42.97, close to its 52-week low of $42.08.
According to TipRanks.com, Shi is a 1-star analyst with an average return of
Legend Biotech has an analyst consensus of Strong Buy, with a price target consensus of $86.08, which is an 86.0% upside from current levels. In a report issued on May 7, J.P. Morgan also maintained a Buy rating on the stock with a $79.00 price target.
See the top stocks recommended by analysts >>
Green Thumb Industries (GTBIF)
In a report released today, Neal Gilmer from Haywood maintained a Buy rating on Green Thumb Industries, with a price target of C$24.00. The company’s shares closed last Monday at $13.01.
According to TipRanks.com, Gilmer is a 3-star analyst with an average return of
Currently, the analyst consensus on Green Thumb Industries is a Strong Buy with an average price target of $19.50, implying a 52.8% upside from current levels. In a report issued on April 30, Craig-Hallum also maintained a Buy rating on the stock.
OmniAb (OABI)
Leerink Partners analyst Puneet Souda maintained a Buy rating on OmniAb on May 9 and set a price target of $12.00. The company’s shares closed last Monday at $4.48.
According to TipRanks.com, Souda ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
OmniAb has an analyst consensus of Strong Buy, with a price target consensus of $9.86, which is a 109.8% upside from current levels. In a report issued on April 29, RBC Capital also maintained a Buy rating on the stock with a $7.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on LEGN:
